ArticleAnnals of hematology2026
WT1 mRNA in peripheral blood enables early prognostic stratification in AML patients receiving venetoclax and azacitidine therapy.
Hiroyuki Sugiura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.